Review
The epidemiology of EBV and its association with malignant disease
In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 53.
Affiliations
- PMID: 21348109
- Bookshelf ID: NBK47424
Item in Clipboard
Review
The epidemiology of EBV and its association with malignant disease
Excerpt
Epstein-Barr virus (EBV) is an ancient virus, and has probably coevolved with its different hosts over the last 90–100 million years (McGeoch et al., 1995). With the ability to establish lifelong latency and intermittent reactivation after primary infection and with limited clinical symptoms in the majority of infected individuals, EBV has become ubiquitous in all human populations
Copyright © Cambridge University Press 2007.
Sections
Similar articles
-
Clinical and pathological aspects of EBV and KSHV infection.In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 50. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 50. PMID: 21348099 Free Books & Documents. Review.
-
Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.J Virol. 2015 Feb;89(3):1731-43. doi: 10.1128/JVI.02781-14. Epub 2014 Nov 19. J Virol. 2015. PMID: 25410866 Free PMC article.
-
Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders.J Am Acad Dermatol. 2015 Jan;72(1):1-19; quiz 19-20. doi: 10.1016/j.jaad.2014.07.034. J Am Acad Dermatol. 2015. PMID: 25497917 Review.
-
Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.J Virol. 2016 Jan 13;90(7):3469-79. doi: 10.1128/JVI.02830-15. J Virol. 2016. PMID: 26764001 Free PMC article.
-
[Hodgkin's disease and Epstein-Barr virus].Ann Biol Clin (Paris). 2004 Nov-Dec;62(6):639-48. Ann Biol Clin (Paris). 2004. PMID: 15563422 Review. French.
References
-
- Abdel-Hamid M., Chen J. J., Constantine N., Massoud M., Raab-Traub N. EBV strain variation: geographical distribution and relation to disease state. Virology. 1992;190:168–175. - PubMed
-
- Aguilar L. K., Rooney C. M., Heslop H. E. Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation. Curr. Opin. Oncol. 1999;11(2):96–101. - PubMed
-
- Aitken C., Sengupta S. K., Aedes C., Moss D. J., Sculley T. B.1994Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus J. Gen. Virol. 75(Pt 1):95–100. - PubMed
-
- Alexander F. E., Lawrence D. J., Freeland J., et al. An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin’s disease (HD): evidence for a specific association with EBV+ve HD in young adults. Int. J. Cancer. 2003;107(2):298–302. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
